// App-Quantinova.ai

e15605 : Serum albumin to globulin ratio as an indicator for the prognosis for cholangiocarcinoma.

Researchers

Presenter

  • Qu Lin

Principal Investigators

  • Zhi-Huan Lin

  • Jie Chen

  • Mingsheng Huang

  • Xing Li

  • Jun-rong Jiang

  • Min Dong

  • Tian-tian Wang

  • Dong-hao Wu

  • Xiao-kun Ma

Medical Centers

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Oncology, Central Hospital of Hengyang, Hengyang, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved